These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29208897)

  • 1. Network dynamics-based cancer panel stratification for systemic prediction of anticancer drug response.
    Choi M; Shi J; Zhu Y; Yang R; Cho KH
    Nat Commun; 2017 Dec; 8(1):1940. PubMed ID: 29208897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating a therapeutic window for precision medicine by integrating genomic profiles and p53 network dynamics.
    Choi M; Park SM; Cho KH
    Commun Biol; 2022 Sep; 5(1):924. PubMed ID: 36071176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attractor landscape analysis reveals feedback loops in the p53 network that control the cellular response to DNA damage.
    Choi M; Shi J; Jung SH; Chen X; Cho KH
    Sci Signal; 2012 Nov; 5(251):ra83. PubMed ID: 23169817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate.
    Eliaš J; Dimitrio L; Clairambault J; Natalini R
    Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):232-47. PubMed ID: 24113167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of senescence in cancer cells by 5'-Aza-2'-deoxycytidine: Bioinformatics and experimental insights to its targets.
    Putri JF; Widodo N; Sakamoto K; Kaul SC; Wadhwa R
    Comput Biol Chem; 2017 Oct; 70():49-55. PubMed ID: 28802167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to escape the cancer attractor: rationale and limitations of multi-target drugs.
    Huang S; Kauffman S
    Semin Cancer Biol; 2013 Aug; 23(4):270-8. PubMed ID: 23792873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
    Engelmann D; Pützer BM
    Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in adenovirus-mediated p53 cancer gene therapy.
    Tazawa H; Kagawa S; Fujiwara T
    Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-based approaches for drug response prediction and targeted therapy development in cancer.
    Dorel M; Barillot E; Zinovyev A; Kuperstein I
    Biochem Biophys Res Commun; 2015 Aug; 464(2):386-91. PubMed ID: 26086105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A link prediction approach to cancer drug sensitivity prediction.
    Turki T; Wei Z
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):94. PubMed ID: 28984192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex regulation of autophagy in cancer - integrated approaches to discover the networks that hold a double-edged sword.
    Kubisch J; Türei D; Földvári-Nagy L; Dunai ZA; Zsákai L; Varga M; Vellai T; Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):252-61. PubMed ID: 23810837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Propagation Predicts Drug Synergy in Cancers.
    Li H; Li T; Quang D; Guan Y
    Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.
    Chari NS; Pinaire NL; Thorpe L; Medeiros LJ; Routbort MJ; McDonnell TJ
    Apoptosis; 2009 Apr; 14(4):336-47. PubMed ID: 19229632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modeling and computational prediction of cancer drug resistance.
    Sun X; Hu B
    Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
    Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
    Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 in breast cancer subtypes and new insights into response to chemotherapy.
    Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
    Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
    Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
    Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.